Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06002945 · ClinicalTrials.gov registry record
Exploring Outcomes and Characteristics of Myasthenia Gravis 2
A clinical trial of Myasthenia Gravis, sponsored by Yale University.
- Active
- Registry status
- 400
- Enrollment target
- 10
- Study locations
NCT06002945 is a study of Myasthenia Gravis that is active but no longer recruiting, run by Yale University. The registered enrollment target is 400 participants, above the 179-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (123% higher). The trial reports 10 study locations across 7 states.
The verdict
NCT06002945, a study of Myasthenia Gravis, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.
Conditions Studied
Interventions
- OTHER Blood sample
Study Locations (10)
North Carolina
- University of North Carolina - Chapel Hill
- Duke University Medical Center - Durham
- Wake Forest University - Winston-Salem
California
- University of California-Irvine - Irvine
- Cedars Sinai Medical Center - Los Angeles
Connecticut
- Yale University - New Haven
District of Columbia
- George Washington University - Washington D.C.
Illinois
- University of Chicago - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06002945
The ClinicalTrials.gov registry entry for NCT06002945 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 179-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (123% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Blood sample is the first listed.
NCT06002945 reports 10 study locations spanning 7 distinct geographic areas - top geographies include North Carolina, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT06002945 about?
NCT06002945 is a clinical study titled "Exploring Outcomes and Characteristics of Myasthenia Gravis 2". The goal of this prospective observational study is to create a network repository of clinical data and biological samples to help researchers learn more about myasthenia gravis.
What is the current status of trial NCT06002945?
This trial is currently active not recruiting. The enrollment target is 400 participants. The study started on 2021-01-12. Estimated completion is 2026-12.
What conditions does trial NCT06002945 study?
This clinical trial studies the following conditions: Myasthenia Gravis.
What interventions are being tested in trial NCT06002945?
The interventions under investigation include: Blood sample (OTHER).
Who is sponsoring clinical trial NCT06002945?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06002945 being conducted?
This trial has 10 study locations across California, Connecticut, District of Columbia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.